With North Carolina Governor Roy Cooper in attendance, Pfizer has announced plans to add 28 new jobs and initiate a $66 million investment in their Sanford facility. The driving force of this initiative is production of Nimenrix, a new product line for Pfizer that provides a vaccine for various forms of meningitis.
Pfizer purchased Nimenrix intellectual property from Wyeth in 2015 and began plans to migrate its production from Belgium to the Sanford facility on Hawkins Avenue. Governor Cooper cited the area’s skilled workforce as a major factor in attracting more business. He also commented that, “The kind of good paying jobs that Pfizer brings to our state are welcome. One of the things I know is the employees who work here save lives every single day. And when they go home at night they can think about the fact that the vaccines and other medicines they make help people every day.”
Over 400 workers are already employed at Pfizer in Sanford. The pharmaceutical corporation indicates that the hiring process for the new wave of workers is already underway.